Form 8-K - Current report:
SEC Accession No. 0001493152-23-021704
Filing Date
2023-06-16
Accepted
2023-06-16 17:00:41
Documents
13
Period of Report
2023-06-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45075
  Complete submission text file 0001493152-23-021704.txt   262850

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cing-20230615.xsd EX-101.SCH 3986
3 XBRL DEFINITION FILE cing-20230615_def.xml EX-101.DEF 26635
4 XBRL LABEL FILE cing-20230615_lab.xml EX-101.LAB 36718
5 XBRL PRESENTATION FILE cing-20230615_pre.xml EX-101.PRE 25259
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5478
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

EIN.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40874 | Film No.: 231022092
SIC: 2834 Pharmaceutical Preparations